Searching for the Culprit: When Diabetic Ketoacidosis Presents With Insulin Autoantibodies

医学 糖尿病酮症酸中毒 胰岛素 自身抗体 低血糖 儿科 美罗华 重症监护医学 罪魁祸首 免疫学 内科学 抗体 心肌梗塞
作者
Scarlette A. Garcia-Avila,Anish Samuel,Iqra N. Farooqi,Rajapriya Manickam,Mourad Ismail,Saleh I. Khaddash,Sandra Gibiezaite
出处
期刊:AACE clinical case reports [Elsevier BV]
卷期号:7 (2): 158-162 被引量:4
标识
DOI:10.1016/j.aace.2020.12.004
摘要

OBJECTIVE: The main objective was to describe and review a unique case that presented with diabetic ketoacidosis, positive insulin autoantibodies (IAAbs, which are found in Hirata disease and are usually present with hypoglycemia), and laboratory findings characteristic of type B insulin resistance syndrome (TBIRS) and systemic lupus erythematosus. Confirmation of TBIRS was obtained in Germany as immunoassay for insulin receptor antibodies (IRAbs) is not available in the United States. METHODS: A literature review on TBIRS and cases that present with IAAbs and IRAbs simultaneously was conducted. RESULTS: We found 6 cases presenting with hypoglycemia, both antibodies, and treatment attempts with various management approaches that were different from the proposed National Institutes of Health (NIH) protocol for TBIRS. Our case is distinct because of the demographic background, presentation with diabetic ketoacidosis, comparatively lower insulin requirement, and no significant hypoglycemic episodes in the third phase. CONCLUSION: We propose that access to IRAb immunoassays may be important for diagnosing milder cases of TBIRS, while IAAbs may provide prognostic and therapeutic insights. Despite completely different presentation from other TBIRS patients reviewed, we observed that the proposed NIH protocol consisting of dexamethasone, rituximab, and cyclophosphamide was successfully employed in our patient. Thus, we propose that our case and the findings regarding antibody testing and the NIH treatment regimen may assist clinicians with earlier recognition and effective management of milder cases of TBIRS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S的应助被爱you采纳,获得10
刚刚
所所的应助被爱you采纳,获得10
刚刚
Orange的应助被April采纳,获得10
刚刚
诸葛明明的应助被迷糊采纳,获得10
1秒前
1秒前
Eric的应助被Danlu采纳,获得10
2秒前
Junzhuo Zhou完成签到,获得积分10
3秒前
Akim的应助被zfr采纳,获得10
4秒前
4秒前
桐桐的应助被Pluto采纳,获得20
5秒前
Endwalker发布了新的文献求助10
5秒前
5秒前
沉默白猫完成签到 ,获得积分10
5秒前
pear发布了新的文献求助10
6秒前
6秒前
搞笑煎蛋完成签到 ,获得积分10
6秒前
7秒前
大力思雁发布了新的文献求助10
7秒前
欢喜初雪完成签到 ,获得积分10
7秒前
固拉多完成签到,获得积分10
7秒前
zenghong发布了新的文献求助10
9秒前
10秒前
11秒前
星辰大海的应助被Endwalker采纳,获得10
11秒前
horse82发布了新的文献求助10
12秒前
12秒前
李健的应助被四仰化三铁采纳,获得10
12秒前
大个的应助被LANER采纳,获得10
13秒前
赵国良完成签到 ,获得积分10
14秒前
飞跃极限发布了新的文献求助10
16秒前
16秒前
李健的应助被科研通管家采纳,获得10
16秒前
英姑的应助被科研通管家采纳,获得10
16秒前
Ava的应助被zenghong采纳,获得10
16秒前
君为臣纲的应助被科研通管家采纳,获得30
16秒前
无花果的应助被科研通管家采纳,获得10
16秒前
共享精神的应助被科研通管家采纳,获得10
16秒前
QDU的应助被科研通管家采纳,获得20
17秒前
跳跃夜白完成签到 ,获得积分10
17秒前
共享精神的应助被科研通管家采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194174
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869209
捐赠科研通 7793764
什么是DOI,文献DOI怎么找? 3437545
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484291